SEARCH

SEARCH BY CITATION

References

  • Almeida MQ, Brito LP, Domenice S, Costa MH, Pinto EM, Osorio CA, Latronico AC, Mendonca BB, Fragoso MC. 2008. [Absence of PRKAR1A loss of heterozygosity in laser-captured microdissected pigmented nodular adrenocortical tissue from a patient with Carney complex caused by the novel nonsense mutation p.Y21X.]. Arq Bras Endocrinol Metabol 52:12571263.
  • Amieux PS, McKnight GS. 2002. The essential role of RI alpha in the maintenance of regulated PKA activity. Ann NY Acad Sci 968:7595.
  • Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X, Stratakis CA. 2003. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res 63:53085319.
  • Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Rene-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA. 2009. Mutations in regulatory subunit type 1A of cyclic AMP-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 94:20852091.
  • Blyth M, Huang S, Maloney V, Crolla JA, Karen Temple I. 2008. A 2.3 Mb deletion of 17q24.2-q24.3 associated with ‘Carney Complex plus’. Eur J Med Genet 51:672678.
  • Bridge J, Sanger W, Mosher G, Buehler B, Hearty C, Olney A, Fordyce R. 1985. Partial duplication of distal 17q. Am J Med Genet 22:229235.
  • Carney JA, Hruska LS, Beauchamp GD, Gordon H. 1986. Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 61:165172.
  • Carney JA. 1995. Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Semin Dermatol 14:9098.
  • Casey M, Mah C, Merliss AD, Kirschner LS, Taymans SE, Denio AE, Korf B, Irvine AD, Hughes A, Carney JA, Stratakis CA, Basson CT. 1998. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 98:25602566.
  • Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC, Basson CT. 2000. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 106:R31R38.
  • Cazabat L, Libe R, Perlemoine K, Rene-Corail F, Burnichon N, Gimenez-Roqueplo AP, Dupasquier-Fediaevsky L, Bertagna X, Clauser E, Chanson P, Bertherat J, Raffin-Sanson ML. 2007. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol 157:18.
  • Gennari M, Stratakis CA, Hovarth A, Pirazzoli P, Cicognani A. 2008. A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generations. Clin Endocrinol (Oxf) 69:751755.
  • Greene EL, Horvath AD, Nesterova M, Giatzakis C, Bossis I, Stratakis CA. 2008. In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay. Hum Mutat 29:633639.
  • Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA, Bertherat J. 2002. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 71:14331442.
  • Groussin L, Horvath A, Jullian E, Boikos S, Rene-Corail F, Lefebvre H, Cephise-Velayoudom FL, Vantyghem MC, Chanson P, Conte-Devolx B, Lucas M, Gentil A, Malchoff CD, Tissier F, Carney JA, Bertagna X, Stratakis CA, Bertherat J. 2006. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 91:19431949.
  • Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS. 2003. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424429.
  • Gu YY, Chen Y, Song HD, Li XY, Luo TH, Qiao JO, Zhang Y, Xiao JC, Zhu Y, Zhao YJ, Luo BY, Ning G. 2004. [Clinical and molecular research in a case of familial Carney complex]. Zhonghua Nei Ke Za Zhi 43:764768.
  • Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, Courkoutsakis N, Abu-Asab M, Tsokos M, Keil M, Carney JA, Stratakis CA. 2004. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 89:31733182.
  • Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, Keil M, Heyerdahl S, Matyakhina L, Libé R, Fratticci A, Kirschner LS, Cramer K, Gaillard RC, Bertagna X, Carney JA, Bertherat J, Bossis I, Stratakis CA. 2006a. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38:794800.
  • Horvath A, Giatzakis C, Robinson-White A, Boikos S, Levine E, Griffin K, Stein E, Kamvissi V, Soni P, Bossis I, de Herder W, Carney JA, Bertherat J, Gregersen PK, Remmers EF, Stratakis CA. 2006b. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res 66:1157111575.
  • Horvath A, Bossis I, Giatzakis C, Levine E, Weinberg F, Meoli E, Robinson-White A, Siegel J, Soni P, Groussin L, Matyakhina L, Verma S, Remmers E, Nesterova M, Carney JA, Bertherat J, Stratakis CA. 2008a. Large deletions of the PRKAR1A gene in Carney complex. Clin Cancer Res 14:388395.
  • Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libe R, Patronas Y, Robinson-White A, Remmers E, Bertherat J, Nesterova M, Stratakis CA. 2008b. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet 16:12451253.
  • Huang LJ, Durick K, Weiner JA, Chun J, Taylor SS. 1997a. D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc Natl Acad Sci USA 94:1118411189.
  • Huang LJ, Durick K, Weiner JA, Chun J, Taylor SS. 1997b. Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. J Biol Chem 272:80578064.
  • Imai Y, Taketani T, Maemura K, Takeda N, Harada T, Nojiri T, Kawanami D, Monzen K, Hayashi D, Murakawa Y, Ohno M, Hirata Y, Yamazaki T, Takamoto S, Nagai R. 2005. Genetic analysis in a patient with recurrent cardiac myxoma and endocrinopathy. Circ J 69:994995.
  • Kinderman FS, Kim C, von Daake S, Ma Y, Pham BQ, Spraggon G, Xuong NH, Jennings PA, Taylor SS. 2006. A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase. Mol Cell 24:397408.
  • Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. 2000a. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:8992.
  • Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. 2000b. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet 9:30373046.
  • Levin ML, Shaffer LG, Lewis R, Gresik MV, Lupski JR. 1995. Unique de novo interstitial deletion of chromosome 17, del(17) (q23.2q24.3) in a female newborn with multiple congenital anomalies. Am J Med Genet 55:3032.
  • Mabuchi T, Shimizu M, Ino H, Yamguchi M, Terai H, Fujino N, Nagata M, Sakata K, Inoue M, Yoneda T, Mabuchi H. 2005. PRKAR1A gene mutation in patients with cardiac myxoma. Int J Cardiol 102:273277.
  • Meoli E, Bossis I, Cazabat L, Mavrakis M, Horvath A, Stergiopoulos S, Shiferaw ML, Fumey G, Perlemoine K, Muchow M, Robinson-White A, Weinberg F, Nesterova M, Patronas Y, Groussin L, Bertherat J, Stratakis CA. 2008. Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors. Cancer Res 68:31333141.
  • Mitchell MK, Gregersen PK, Johnson S, Parsons R, Vlahov D. 2004. The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health 81:301310.
  • Olney PN, Kean LS, Graham D, Elsas LJ, May KM. 1999. Campomelic syndrome and deletion of SOX9. Am J Med Genet 84:2024.
  • Perdigao PF, Stergiopoulos SG, De Marco L, Matyakhina L, Boikos SA, Gomez RS, Pimenta FJ, Stratakis CA. 2005. Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas. Genes Chromosomes Cancer 44:204211.
  • Pereira AM, Hes FJ, Horvath A, Greene E, Bimpaki E, Boikos S, Woortman S, Smit JW, Romijn JA, Nesterova M, Stratakis CA. 2010. The M1V PRKAR1A mutation is associated with only primary pigmented nodular adrenocortical disease in two large families. J Clin Endocrinol Metab 95:338342.
  • Robinson-White A, Meoli E, Stergiopoulos S, Horvath A, Boikos S, Bossis I, Stratakis CA. 2006a. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex. J Clin Endocrinol Metab 91:23802388.
  • Robinson-White AJ, Leitner WW, Aleem E, Kaldis P, Bossis I, Stratakis CA. 2006b. PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes. Cancer Res 66:1060310612.
  • Sandrini F, Matyakhina L, Sarlis NJ, Kirschner LS, Farmakidis C, Gimm O, Stratakis CA. 2002. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. Genes Chromosomes Cancer 35:182192.
  • Sasaki A, Horikawa Y, Suwa T, Enya M, Kawachi S, Takeda J. 2008. Case report of familial Carney complex due to novel frameshift mutation c.597del C (p.Phe200LeufsX6) in PRKAR1A. Mol Genet Metab 95:182187.
  • Shabb JB. 2001. Physiological substrates of cAMP-dependent protein kinase. Chem Rev 101:23812411.
  • Skalhegg BS, Tasken K, Hansson V, Huitfeldt HS, Jahnsen T, Lea T. 1994. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 263:8487.
  • Skamrov AV, Feoktistova ES, Khaspekov GL, Kovalevskii DA, Goriunova LE, Bibilashvili R, Vinnitskii LI, Sheremet'eva GF, Nechaenko MA. 2003. [[PRKAR1A gene mutations in two patients with myxoma syndrome (Carney complex)]. Kardiologiia 43:7782.
  • Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP. 1996. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97:699705.
  • Stratakis CA, Kirschner LS, Carney JA. 1998. Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas. Am J Med Genet 80:183185.
  • Stratakis CA, Kirschner LS, Carney JA. 2001. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:40414046.
  • Tasken K, Skalhegg BS, Tasken KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, Vang T, Schrader HP, Reinton NT, Torgersen KM, Hansson V, Jahnsen T. 1997. Structure, function, and regulation of human cAMP-dependent protein kinases. Adv Second Messenger Phosphoprotein Res 31:191204.
  • Vargas-Alarcon G, Vargas-Barron J, Cruz-Robles D, Perez-Vielma N, Garcia-Trejo JJ, Aguilar-Gaytan R, Cortes-Hernandez P, Vazquez-Ortiz ZY, Romero-Cardenas A. 2008. A deletion in the PRKAR1A gene is associated with Carney complex. J Pediatr Endocrinol Metab 21:705709.
  • Veugelers M, Wilkes D, Burton K, McDermott DA, Song Y, Goldstein MM, La Perle K, Vaughan CJ, O'Hagan A, Bennett KR, Meyer BJ, Legius E, Karttunen M, Norio R, Kaariainen H, Lavyne M, Neau JP, Richter G, Kirali K, Farnsworth A, Stapleton K, Morelli P, Takanashi Y, Bamforth JS, Eitelberger F, Noszian I, Manfroi W, Powers J, Mochizuki Y, Imai T, Ko GT, Driscoll DA, Goldmuntz E, Edelberg JM, Collins A, Eccles D, Irvine AD, McKnight GS, Basson CT. 2004. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci USA 101:1422214227.
  • Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. 1991. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:16881695.
  • Witsch-Baumgartner M, Clayton P, Clusellas N, Haas D, Kelley RI, Krajewska-Walasek M, Lechner S, Rossi M, Zschocke J, Utermann G. 2005. Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. Hum Mutat 25:412.
  • Wong W, Scott JD. 2004. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5:959970.
  • Zawadzki KM, Taylor SS. 2004. cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP. J Biol Chem 279:70297036.